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Background: Influenza epidemics are a major health care concern in the US. Influenza related
complications can increase in-hospital complications, and readmissions following a hospitalization for
influenza. We sought to determine the 30-day readmission rate, etiologies, outcomes, and healthcare burden
of 30-day readmissions in adults hospitalized for influenza.
Methods: The 2014 US National Readmissions Database (NRD) was retrospectively analyzed to identify
patients ≥18 years of age hospitalized for influenza and discharged between January and November 2014.
We used this time frame as this was the most recent data available for analysis and included patients who had
30-day follow-up. Survey design based multivariable logistic regression models were used to identify factors
associated with a 30-day readmission.
Results: Of the 46,117 patients who were hospitalized for influenza and survived to discharge, 4,721 (10.2%)
patients had 5,275 30-day readmissions, estimated to 11.4 readmissions per 100 patients. Non-influenza
pneumonia was the most common etiology of 30-day readmissions (10.4%) followed by sepsis (9.8%). The
median costs of readmissions were $8,538 (IQR, $5,053–15,262), which were significantly higher than the
median costs of their index hospitalizations [$7,863 (IQR, $4,875–13,212); P<0.001]. Around 6.5% of the
patients died during a readmission.
Conclusions: Adult patients hospitalized for influenza had 11.4 30-day readmissions per 100 patients,
most commonly for non-influenza pneumonia. Thirty-day readmissions were associated with higher costs of
care and considerable mortality.
Keywords: Influenza; acute myocardial infarction (AMI); stroke; readmissions; pneumonia
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Introduction
Influenza is a major public health problem in the US
with significant variations in its annual incidence and
public health burden (1). While the majority of influenza
patients are managed in the ambulatory setting, influenza
and related complications can result in hospitalizations
(1,2). The Center for Disease Control (CDC) reported
an estimated minimum 140,000 and maximum 710,000
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hospitalizations for influenza and related complications
between years 2010 and 2016 in the US (1,2). In the US
in year 2003, influenza-related hospitalizations amounted
to $6.0 billion in costs, which were only 7% of the total
economic burden of influenza during that year (3). Among
adult patients hospitalized for influenza, more than twothirds have underlying medical conditions, most commonly
cardiovascular (CV) disease, metabolic disorder, obesity,
and chronic lung disease (4). Further, available data
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suggest an increased risk of adverse CV events like acute
myocardial infarction (AMI) and ischemic cerebrovascular
events (CVEs) in the acute phase following an influenza
infection (5-14).
While such risk of increased adverse events can increase
in-hospital complications, they can also cause readmissions
in these patients in the acute phase following influenza
infection. Readmissions are usually measured within 30
days because readmissions and deaths after a longer time
period may be less influenced by the admitting condition
and care gotten in the hospital and more to do with other
complicating illnesses, patients’ behavior, or care provided
to patients after hospital discharge (15). Data are scarce
regarding the etiology and burden of 30-day readmissions
following a hospitalization for influenza. We sought to
determine the 30-day readmission rates and associated
factors, reasons for readmission and their healthcare
burden, after hospitalization for either influenza-pneumonia
or influenza-related organ system manifestations in adult
patients.
Methods
Data source
In this retrospective observational study, data were collected
from the publicly available 2014 US National Readmissions
Database (NRD). The NRD is part of the Healthcare
Cost and Utilization Project (HCUP) that is sponsored
by the Agency for Healthcare Research and Quality
(AHRQ) and is a database of all-payer hospital inpatient
stays that can be used to generate national estimates of
readmissions (16). The NRD is drawn from HCUP
State Inpatient Databases which contain verified patient
linkage numbers that can be used to track a person across
readmissions while maintaining privacy. The NRD includes
community hospitals and excludes rehabilitation or longterm acute care hospitals. Unweighted, the 2014 NRD
contains data from approximately 15 million discharges from
22 partner states: Arkansas, California, Florida, Georgia,
Hawaii, Iowa, Louisiana, Maryland, Massachusetts,
Missouri, Nebraska, New Mexico, Nevada, New York,
South Carolina, South Dakota, Tennessee, Utah, Virginia,
Vermont, Washington, and Wisconsin. These states are
geographically dispersed and account for 51.2% of the total
US resident population and 49.3% of all hospitalizations.
Weighted, it estimates roughly 35 million discharges (16).
The NRD was post-stratified by hospital characteristics
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(census region, urban/rural location, hospital teaching
status, size of the hospital defined by the number of beds,
and hospital control) and patient characteristics [sex and five
age groups (0, 1–17, 18–44, 45–64, and 65 and older)] (16).
Discharge weights (variable DISCWT) were provided to
obtain national estimates.
Patient population and baseline characteristics
The study sample included all adult patients (≥18 years)
who were discharged alive between January and November
2014 with a primary discharge diagnosis of influenza
pneumonia or other influenza-related manifestations.
These cases formed our index cohort. Patients discharged
in December were excluded because the NRD design will
not allow for 30-day follow-up of patients discharged in
this month. International Classification of Diseases, Ninth
Edition, Clinical Modification (ICD-9-CM) diagnosis codes
487 and 488 were used to identify influenza diagnoses.
We chose data from 2014 for our study as these were the
most recently available data which used ICD-9 codes
throughout for coding diagnosis. If a patient had multiple
hospitalizations for influenza during the study period, only
the first hospitalization for influenza was included in the
index cohort. We did not include hospitalizations with a
secondary discharge diagnosis of influenza because such
hospitalizations could include patients with previously
diagnosed influenza, co-incidental influenza diagnosis, and
also hospital-acquired influenza when admitted for other
reasons.
Baseline patient characteristics identified in the index
cohort were age, sex, primary expected payer, median
household income, comorbidities (anemia, atrial fibrillation,
cancer, chronic lung disease, coagulopathy, depression,
drug abuse, dementia, diabetes mellitus, hypertension,
hypothyroidism, fluid-electrolyte imbalances, liver disease,
obesity, other neurological disorders, paralysis, psychoses,
peripheral vascular disease, pulmonary circulation
disorders, chronic renal failure, and heart failure), inhospital complications [septicemia and shock, AMI,
acute kidney injury (AKI), ischemic stroke and transient
cerebral ischemic events, gastrointestinal hemorrhage,
and respiratory failure), type and day of admission, and
discharge disposition. Hospital characters (location, bedsize, and teaching status) were also identified. Elixhauser
comorbidity data were extracted from the NRD. ICD9-CM and the HCUP Clinical Classification Software
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(CCS) codes used to identify comorbidities and in-hospital
complications are available in Table S1.
Study outcomes
The primary outcomes of this study were the 30-day
readmission rate from the day of discharge, etiology
for readmission, and the factors associated with 30-day
readmissions. Secondary outcomes were comparison of
length of stay (LOS) and costs of care between index
hospitalization and readmission, and all-cause in-hospital
mortality during 30-day readmissions only because all
patients in our index cohort survived to discharge. LOS and
costs of hospitalization were identified in both index cases
and readmission, whereas, all-cause inpatient mortality was
identified in 30-day readmissions. Methodology described
by the HCUP to identify readmissions was used to
identify 30-day readmissions (16). Total number of 30-day
readmissions and the number of index-patients readmitted
within 30-day were identified and expressed as proportion
of the index hospitalizations. Time to readmission was
calculated as the duration between index-hospital discharge
and the first day of hospital readmission.
Etiologies of readmissions were recognized by
identifying the ICD-9-CM diagnosis codes and the HCUP
CCS codes of the primary discharge diagnosis of each
individual readmission (available in Table S2). Causes of
readmissions were classified on the basis of organ system
involvement into respiratory, CV, infection-related,
neurovascular, peripheral vascular, hematologic and
cancer related, gastrointestinal, renal and fluid-electrolyte
disorders, endocrine and metabolic, neuropsychiatric
and substance abuse-related, musculoskeletal and injury
related, symptom related (fever of unknown origin, malaise,
abdominal pain, nausea/vomiting), complication of devicegraft-implant, or others. Respiratory causes included noninfluenza pneumonia and empyema, influenza, obstructive
lung disease, pleural disease, respiratory failure, aspiration
pneumonitis, and others. CV causes included heart failure,
arrhythmias and conduction disorders, AMI, hypertension,
coronary artery disease, pulmonary embolism, syncope,
and chest pain. Infection-related etiologies included sepsis,
intestinal infections, skin infections, urinary tract infections
(UTIs), and others.
To identify costs of hospitalization, hospital reported
charges (variable TOTCHG) were multiplied with the costto-charge ratios developed and reported by the AHRQ.
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Statistical analysis
All statistical analyses were performed using IBM SPSS
Statistics 25.0 (IBM Corp., Armonk, NY, USA). Weighted
data were used for all statistical analyses. Categorical
variables are expressed as percentages, and continuous
variables as mean ± standard deviation (SD). Because the
distributions of LOS and total hospital costs were skewed
to the right, median [interquartile range (IQR)] were also
reported. Baseline patient characters, comorbidities and
complications, and hospital characteristics were compared
between patients with and without 30-day readmission
using Pearson χ2 test for categorical variables and student
t-test for continuous variables. Nonparametric MannWhitney U test was used to compare medians between
patient groups. Since the NRD has a complex semirandom multistage sampling survey design, survey design
based multivariable logistic regression model [designed to
test for 95% confidence intervals (CIs) and a two-sided P
value threshold of <0.05] was designed to identify factors
associated with 30-day readmissions. The regression model
included all the variables which achieved a P value <0.2 in
unadjusted analysis. In the NRD, patients’ aged ≥90 years
were reported as 90-year-old. This can affect the results
when age (in years) is used as a covariate in statistical
analysis. Hence, patients were sub grouped into three age
categories (18–44, 45–64, and ≥65 years). LOS of index
hospitalizations was included in the regression model as a
categorical variable divided into 2 groups based on median
LOS cut-off. Results of the logistic regression analyses were
reported as odds ratios (ORs) and 95% CIs.
Around ≤1% data were missing for the variables
primary payer status, median household income, discharge
disposition, and type of admission (elective versus nonelective). Missing values were replaced with the dominant
categories. Total hospital charge data were missing for
around 1% index-hospitalizations and 0.9% of the 30-day
readmission. Reported cost data were for the remainder of
the cases.
Results
Baseline characteristics of the study cohort and in-hospital
complications
The index-study cohort included 46,117 adult patients
who had influenza hospitalization meeting our index-case
criteria and survived to discharge. These patients had a
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mean age ± SD of 61.1±17.9 years and 53.6% were female.
Of these, 22,457 (48.7%) were primarily hospitalized for
influenza-pneumonia, 22,375 (48.5%) for influenza-related
respiratory symptoms, and 1,285 (2.8%) for other organsystem manifestations of influenza. Overall, around 44.5%
patients were elderly with age ≥65 years. Baseline patient
demographics, comorbidities, in-hospital complications,
and hospital characteristics for the overall index-study
cohort are presented in Table 1. More patients (31.1%) were
in the lowest median income quartile ($1–39,999) group
and around two-thirds had either Medicare or Medicaid
health insurance. Hypertension, chronic pulmonary disease,
diabetes mellitus, fluid-electrolyte disturbances, and anemia
were the most prevalent comorbidities. While respiratory
failure occurred in 22.1% of index hospitalizations, AKI
complicated 12.8%, an AMI in 1.2%, and ischemic CVE in
0.3%. More patients in the index-cohort were hospitalized
in large-sized urban-based teaching hospitals. Median
LOS was relatively short at 3 days [IQR, 2–6 days] and
mean LOS ± SD was 5.1±6.9 days. The total costs of index
hospitalizations were $489.9 million, mean $10,729±22,255
and median $6,082 (IQR, $3,921–10,220).
Thirty-day readmissions and characteristics of index
hospitalizations by readmission status
Of the 46,117 index-group patients, 4,721 (10.2%) patients
had 5,275 30-day readmissions. This estimates to 11.4
readmissions per 100 patients within a 30-day period from
discharge. Baseline patient demographics, comorbidities,
in-hospital complications, and hospital characters for the
index cases with and without a readmission are presented in
Table 1.
Patients who had a 30-day readmission were generally
older (63.9±17.5 years) compared to those without a
30-day readmission (60.7±17.9 years; P=0.02), more likely
to be insured by Medicare/Medicaid (74.9% vs. 64.6%;
P<0.001), and more likely to have a higher burden of
comorbidities and in-hospital complications. Ischemic
CVEs (0.6% vs. 0.3%; P=0.005), AMI (2.1% vs. 1.2%;
P<0.001), and gastrointestinal bleeding (1.4% vs. 0.7%;
P<0.001) occurred almost two-times the rate in patients
who had a 30-day readmission compared to those who did
not. Patients who had a 30-day readmission had a longer
median initial LOS [4 days (IQR, 3–7 days) vs. 3 days
(IQR, 2–5 days); P<0.001], more likely to be discharged to
a nursing home or other medical facility (20.4% vs. 12.3%;
P<0.001) and had higher median index hospitalization costs
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[$7,863 (IQR $4,875–13,212) vs. $5,946 ($3,830–9,804);
P<0.001].
Factors associated with a 30-day readmission
In multivariable logistic regression analysis results presented
in Table 2, presence of chronic pulmonary disease (OR 1.15;
95% CI, 1.03–1.27), drug abuse (OR 1.53; 95% CI, 1.18–
1.99), liver disease (OR 1.47; 95% CI, 1.12–1.92), chronic
renal failure (OR 1.42; 95% CI, 1.23–1.64), heart failure
(OR 1.45; 95% CI, 1.25–1.69), AKI (OR 1.24; 95% CI,
1.07–1.44), anemia (OR 1.32; 95% CI, 1.17–1.50), cancer
(OR 1.93; 95% CI, 1.56–2.39), and sepsis (OR 1.31; 95%
CI, 1.01–1.68) were associated with a 30-day readmission.
A longer LOS >3 days (OR 1.48; 95% CI, 1.31–1.67),
discharge to nursing home/other medical facility (OR 1.23;
95% CI, 1.07–1.44), and admission to a teaching hospital
(OR 1.15; 95% CI, 1.03–1.29) also predicted a 30-day
readmission.
Timing and causes of 30-day readmissions
Of the 5,275 readmissions, 45.8% were within 10 days
from discharge, 29.3% between days 11–20, and 24.8%
between days 21–30. Median time to readmission was
12 days (IQR, 5–20 days). Etiologies of readmissions
were presented in Table 3. When stratified according
to organ-system involvement, most common causes of
30-day readmission were respiratory (31.2%), infectious
(15.8%), CV (14.9%), gastrointestinal (7.6%), and
hematologic-cancer related (4.9%). Diagnosis wise, noninfluenza pneumonia was the most common etiology of
30-day readmissions (10.4%), followed by sepsis (9.8%),
obstructive lung disease (8.0%), heart failure (6.2%), AKI
and UTIs at 2.3% each. While a microbiological diagnosis
was not made in most non-influenza pneumonias (78.4%),
methicillin-resistant Staphylococcus aureus (MRSA) was the
most frequently identified organism (4.8%) in the rest.
Similarly, around 81% of the sepsis-related admissions did
not have a microbiologic diagnosis, but when an organism
was identified, it was more often gram-positive (12%; 5%
streptococcal and 4% MRSA).
LOS, costs, and mortality related to 30-day readmissions
Overall, 6.5% of the patients readmitted within 30-days
from discharge died during a readmission. Mortality was
highest when the readmission etiology was infectious,
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Table 1 Baseline characteristics, comorbidities, in-hospital complication, and outcomes of patients in the index-cohort with and without a 30-day
readmission
Baseline characteristics

Total, % (N=46,117)

30-day readmission
No, % (N=41,396)

Yes, % (N=4,721)

P value

Patient variables
Age (years)

<0.001

18–44

18.7

19.2

14.2

45–64

36.8

37.1

34.1

65 and above

44.5

43.7

51.7

Sex

0.081

Female

53.6

53.8

52.4

Male

46.4

46.2

47.6

Median household income

0.394

$1–39,999

31.1

31.2

30.2

$40,000–50,999

26.4

26.2

27.6

$51,000–65,999

21.9

22.0

20.7

$66,000 or more

20.7

20.6

21.5

Medicare/Medicaid

65.7

64.6

74.9

Private

25.4

26.1

19.6

Uninsured

6.6

6.9

3.8

Others

2.3

2.4

1.8

Anemia

17.5

16.4

26.4

<0.001

Atrial fibrillation

13.1

12.5

18.5

<0.001

Cancer

5.1

4.7

8.9

<0.001

Chronic pulmonary disease

40.3

39.9

43.6

<0.001

Chronic renal failure

15.6

14.4

25.8

<0.001

Coagulopathy

8.0

7.7

9.9

<0.001

Heart failure

15.1

13.9

25.5

<0.001

Primary payer

<0.001

Comorbidities

Dementia

7.8

7.5

10.3

<0.001

Depression

13.1

12.8

15.2

<0.001

Diabetes mellitus

30.0

29.4

35.5

<0.001

Drug abuse

3.3

3.2

4.6

<0.001

Fluid and electrolyte disorders

41.7

41.5

43.3

0.021

Hypertension

58.9

58.2

64.8

<0.001

Hypothyroidism

13.0

12.8

14.3

0.004

Liver disease

2.8

2.7

4.4

<0.001

Obesity

16.6

16.8

15.4

0.019

Other neurological disorders

9.7

9.4

11.6

<0.001

Table 1 (continued)
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Table 1 (continued)
Baseline characteristics

Total, % (N=46,117)

30-day readmission
No, % (N=41,396)

Yes, % (N=4,721)

P value

Paralysis

2.3

2.2

3.2

<0.001

Peripheral vascular disease

4.4

4.1

6.4

<0.001

Psychoses

5.2

5.1

6.0

0.006

Pulmonary circulation disorders

4.2

3.9

6.8

<0.001

AMI

1.2

1.1

2.1

<0.001

AKI

12.8

12.1

19.7

<0.001

Sepsis and shock

2.8

2.6

4.4

<0.001

Respiratory failure

22.1

21.4

28.2

<0.001

Gastrointestinal hemorrhage

0.8

0.7

1.4

<0.001

Ischemic CVE

0.3

0.3

0.6

0.005

Median LOS

3 days

3 days

4 days

<0.001

≤3 days

51.9

53.5

37.4

>3 days

48.1

46.5

62.6

In-hospital complications

Admission day

0.026

Weekday

74.2

74.0

75.5

Weekend

25.8

26.0

24.5

Admission type
Elective

0.110
4.6

4.6

4.1

Disposition

<0.001

Home

86.9

87.7

79.6

Short term hospital, nursing home,
or other facility

13.1

12.3

20.4

Hospital characteristics
Location

0.001

Rural

4.6

4.7

3.6

Urban

95.4

95.3

96.4

Teaching status

<0.001

Non-teaching

40.6

41.1

35.9

Teaching

59.4

58.9

64.1

Bed size

<0.001

Small

18.7

19.0

16.4

Medium

27.8

27.8

27.6

Large

53.5

53.3

56.0

6,082

5,946

7,863

Median cost of care (US $)

<0.001

AMI, acute myocardial infarction; AKI, acute kidney injury; LOS, length of stay; CVE, cerebrovascular event.
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Table 2 Results of the multivariable regression analysis to identify factors associated with increased 30-day readmissions
Factors

Reference category

Multivariable analysis*, OR (95% CI)

LOS ≤3 days

1.48 (1.31–1.67)

Sepsis and septic shock

Absent

1.31 (1.01–1.68)

Cancer

Absent

1.93 (1.56–2.39)

Anemia

Absent

1.32 (1.17–1.50)

AKI

Absent

1.24 (1.07–1.44)

Heart failure

Absent

1.45 (1.25–1.69)

Chronic renal failure

Absent

1.42 (1.23–1.64)

Liver disease

Absent

1.47 (1.12–1.92)

Drug abuse

Absent

1.53 (1.18–1.99)

Chronic pulmonary disease

Absent

1.15 (1.03–1.27)

Home discharge

1.24 (1.07–1.44)

Teaching hospital

Non-teaching hospital

1.15 (1.03–1.29)

Private insurance

Medicare/Medicaid

0.85 (0.74–0.97)

Uninsured

Medicare/Medicaid

0.67 (0.52–0.85)

Non-obese

0.82 (0.69–0.96)

45–64

18–44

1.02 (0.85–1.23)

65 and above

18–44

1.01 (0.84–1.21)

Female sex

1.02 (0.93–1.13)

AMI

Absent

1.08 (0.75–1.56)

Ischemic CVE

Absent

1.05 (0.45–2.47)

Atrial fibrillation

Absent

1.10 (0.95–1.28)

Coagulopathy

Absent

1.04 (0.87–1.24)

Hypertension

Absent

1.01 (0.90–1.13)

Hypothyroidism

Absent

0.98 (0.83–1.15)

Depression

Absent

1.13 (0.97–1.32)

Dementia

Absent

1.06 (0.87–1.29)

Diabetes mellitus

Absent

1.12 (0.99–1.26)

Gastrointestinal bleed

Absent

1.33 (0.87–2.05)

Fluid and electrolyte disorder

Absent

0.93 (0.84–1.04)

Other neurological disorder

Absent

1.09 (0.92–1.30)

Paralysis

Absent

1.28 (0.95–1.74)

Peripheral vascular disease

Absent

1.09 (0.88–1.34)

Psychoses

Absent

1.14 (0.91–1.44)

Pulmonary circulation disorders

Absent

1.22 (0.99–1.49)

LOS >3 days

Discharge to nursing home/other facility

Obesity
Age (years)

Male sex

Table 2 (continued)

© Annals of Translational Medicine. All rights reserved.

atm.amegroups.com

Ann Transl Med 2018;6(16):318

Yandrapalli et al. Readmissions in adult patients after influenza hospitalization

Page 8 of 11

Table 2 (continued)
Factors

Reference category

Multivariable analysis*, OR (95% CI)

Respiratory failure

Absent

1.12 (0.98–1.28)

Elective admission

Non-elective admission

0.95 (0.72–1.26)

Weekend admission

Weekday admission

0.89 (0.79–1.01)

Rural-based hospital

Urban-based hospital

1.02 (0.74–1.39)

Large

Small

1.15 (0.99–1.33)

Medium

Small

1.16 (0.99–1.37)

Bed size of hospital

*

, survey design based multivariable logistic regression model designed to test for 95% confidence intervals and a two-sided P value
of <0.05. OR, odds ratio; CI, confidence intervals; LOS, length of stay; AKI, acute kidney injury; AMI, acute myocardial infarction; CVE,
cerebrovascular event.

Table 3 System based and disease specific etiologies of 30-day
readmission after hospitalization for influenza
Etiology of readmission
Respiratory

30-day readmissions
(N=5,275, %)
1,643 (31.1)

Non-influenza pneumonia and empyema

549 (10.4)

Influenza

190 (3.6)

Chronic obstructive lung disease and
asthma

422 (8.0)

Aspiration pneumonitis

127 (2.4)

Pleural disease

32 (0.6)
223 (4.2)

Other respiratory tract disease

100 (1.9)

Cardiovascular

784 (14.9)

Heart failure

327 (6.2)

Conduction disease and arrhythmias

127 (2.4)
63 (1.2)

Coronary artery disease

37 (0.7)

Hypertension

63 (1.2)

Pulmonary embolism

84 (1.6)

Syncope

32 (0.6)

Nonspecific chest pain

42 (0.8)

Infection-related and septicemia
Septicemia and shock
Intestinal infection
Urinary tract infections

30-day readmissions
(N=5,275, %)

Etiology of readmission
Skin and soft-tissue infection

60 (1.1)

Others

42 (1.0)

Neurovascular

104 (2.0)

Ischemic cerebrovascular events

59 (1.1)

Peripheral vascular

Respiratory failure

Acute myocardial infarction

Table 3 (continued)

835 (15.8)
516 (9.8)
92 (1.7)

91 (1.7)

Endocrine and metabolic

119 (2.3)

Gastrointestinal

402 (7.6)

Gastrointestinal hemorrhage

106 (2.0)

Renal diseases and fluid/electrolyte
imbalance

243 (4.6)

Acute kidney injury

119 (2.3)

Fluid and electrolyte disorder

96 (1.8)

Neuropsychiatric and substance-related

242 (4.6)

Musculoskeletal and injury related

229 (4.3)

Symptom-related

109 (2.0)

Fever of unknown origin

38 (0.7)

Nausea/vomiting

22 (≤0.5)

Abdominal pain

28 (≤0.5)

Malaise and fatigue

15 (≤0.5)

Device, implant, graft complications
Others

129 (2.4)
90 (1.7)

119 (2.3)

Table 3 (continued)
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reaching a high of 21.5% in patient admitted for septicemia.
Median LOS was 4 days (IQR, 3–8 days) with a mean of
6.5±7.6 days. Total costs associated with 30-day readmissions
were around $77.2 million during the study period. Median
readmission costs were $8,538 (IQR, $5,053–15,262) and
mean costs were $14,772±23,348. The median LOS of
the readmissions (4 days) was significantly higher than the
median LOS of all index admissions (3 days; P<0.001), but
was similar to the median LOS of the index cases which had
a readmission (4 vs. 4 days; P=0.77). The median costs of
readmissions ($8,538) were significantly higher compared to
median costs of all index cases ($6,082; P<0.001) and index
cases with a 30-day readmission ($7,863; P<0.001).
Discussion
In this retrospective observational study of a large group
of patients who were representative of the US population
and were primarily hospitalized for influenza in 2014, a
substantial number of patients were readmitted within
30-days from discharge, with an estimated 11.4%
readmission rate.
Respiratory system diseases and infections were the most
common etiologies for a 30-day readmission. Influenza
infection increases the risk of secondary pneumonias’
particularly bacterial (17). In our study, non-influenza
pneumonia was the most common cause of 30-day
readmissions. A microbiological diagnosis was not made in
around four-fifths of the cases in our study, but the most
commonly identified organism was MRSA in 5%. During
influenza epidemics, both Streptococcus pneumonia and
Staphylococcus aureus (more recently MRSA) were identified
as common causes of bacterial pneumonias (17).
Prior studies have reported an increased risk of AMI
and stroke in the acute phase following influenza (5-7,911,13,14,18,19). In our study, AMI and ischemic CVEs
had incident rates of 1.2% and 0.3% respectively and were
infrequent causes of 30-day readmissions (between 1–2%).
However, it must be noted that we only included patients
who survived to discharge during an index hospitalization
in our analysis and the hence did not fully capture incidence
rate of AMI or ischemic CVEs in all adults hospitalized
for influenza. Influenza infection has not been clearly
implicated to cause heart failure and obstructive lung
disease exacerbations (20-22). In our study, hospitalizations
for heart failure, chronic obstructive pulmonary disease, and
asthma were important causes 30-day readmissions.
In our study, increasing age categories and differences
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in sex did not influence 30-day readmission risk. Anemia,
cancer, heart failure, chronic lung disease, liver disease,
and chronic renal failure independently predicted a
30-day readmission. These conditions increase the
comorbid disease burden in patients and can result in
multiple hospitalizations. AMI and ischemic CVEs, which
occurred infrequently in our index group patients, were
not associated with a 30-day readmission. Interestingly,
LOS more than 3 days was independently associated with a
readmission. A longer LOS might suggest a sicker patient
but a LOS higher than the median predicted a readmission
after accounting for common in-hospital complications and
comorbidities. Patients had a higher 30-day readmission
risk when discharged to a nursing home or other medical
facility. Patients discharged to a nursing home should have
more supervision of care to help reduce hospitalizations.
However, patients typically discharged to a nursing facility
are older with a higher comorbidity burden and severity of
illness associated with increased readmissions (23). Early
and appropriate discharge planning to reduce LOS and to
aim for home-discharge with adequate support might help
reduce the readmission rate in this patient group.
Readmissions also represented a significant health-care
and economic burden. Among patients hospitalized within
30 days from discharge, 6.5% died. More patients died
when the cause of readmission was infectious. Appropriate
infection control strategies during index hospitalization
and early identification and treatment of septicemia should
be emphasized to decrease this high mortality rate. The
economic burden of readmissions was higher than the index
admissions despite having a similar LOS. These findings
suggest higher health-care resource utilization during
readmissions.
The strengths of our study are utilization of a large
nationally representative administrative database which
was collected using validated methods to reduce selection
bias. Using validated methodology, we were able to
determine the 30-day readmission rates, identify the
causes and predictors of readmissions, and determine their
economic impact in the real-world patients hospitalized for
influenza (16).
Our study has important limitations. Firstly, administrative
databases lack clinical and laboratory variables which can more
accurately determine duration of infection and patient status.
It is not known if influenza was diagnosed based on clinical
symptoms or laboratory testing in our study. Secondly,
using billing codes to identify causes of hospitalizations
and in-hospital complications can result in misclassification
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bias. Thirdly, data on anti-influenza medication use and
vaccination was not available. We were unable to test the
association of immunization and anti-viral treatment on
readmission risk. Fourthly, our sample included influenza
patients across 2 different seasons (January–November) and
excluded patients discharged in December. The design of
the NRD, which is a yearly database, limited our ability to
perform analysis bases on flu-season. We could not adjust
for viral-strain and seasonal based differences in readmission
rates. Lastly, the NRD does not report out of hospital and
emergency room mortality data, which could influence the
readmission rates.
Conclusions
In conclusion, adult patients hospitalized for influenza had
11.4 30-day readmissions per 100 patients, most commonly
for non-influenza pneumonia and other infections. Thirtyday readmissions were associated with significant healthcare
impact with higher costs of care and considerable mortality.
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Supplementary
Table S1 ICD-9CM and the CCS codes used to identify primary discharge diagnoses, baseline comorbidities, and in-hospital complications
Diagnosis

ICD-9-CM codes

Influenza

CCS codes
123

Influenza-pneumonia

487.0, 488.01, 488.11, 488.81

Other respiratory manifestations

487.1, 488.02, 488.12, 488.82

Other manifestations

487.8, 488.09, 488.19, 488.89

Comorbidities
Dementia
Atrial fibrillation

290.xx, 294.1x, 294.2x, 331.0, 331.1x,
331.82, 331.89
427.31

In-hospital complications
Sepsis

788.52

2

Respiratory failure

131

Gastrointestinal hemorrhage

153

Acute myocardial infarction

410.x1, 411.1

Acute kidney injury

584.x

Ischemic stroke and transient
cerebral ischemia

433.x1

112

x, the ICD-9CM subcode; ICD-9CM, International Classification of Diseases, Ninth Edition, Clinical Modification; CCS, Clinical
Classification Software.

Table S2 ICD-9CM and the CCS codes in the primary discharge diagnosis position used to identify causes of 30-day readmissions
Organ system/diagnosis

CCS codes

Respiratory

56, 122–134

Pneumonia and empyema
Influenza
COPD and asthma
Aspiration pneumonitis

122
123
127, 128
129

Pleural disease

510.9, 511.0, 511.89, 511.9, 512.0,
512.89

Respiratory failure
Other respiratory tract disease

518.8x
125,126,133,134

Cardiovascular

96–108, 245

Heart failure

108

Conduction disease and arrhythmia

100

CAD

101

415.1x

Syncope

245

Nonspecific chest pain

102

Ischemic stroke and transient cerebral ischemia
Peripheral vascular
Hematologic and cancer-related
Endocrine and metabolic
Gastrointestinal
GIB
Renal diseases and fluid/electrolyte imbalance

109–113
112

Fluid and electrolyte disorders

MSK and injury related

434.11, 434.91

114–121
14, 15, 16, 18, 19, 24, 33, 35, 38, 39, 40, 42, 44,
45, 47, 59–63
50, 51, 58
138–141, 143–155
153
55, 157,158, 160–163

AKI
Neuropsychiatric and substance-related

414.04

98,99

Pulmonary embolism

Neurovascular

402.91, 404.91, 404. 93, 788.51

105, 106, 107

AMI
Hypertension

ICD-9-CM codes

584.x
55
81, 83, 84, 85, 93, 95, 651, 653, 654, 657, 659,
660, 661
54, 203–205, 207, 210–212, 226, 229–234, 238–
244

Symptoms
Fever of unknown origin

246

Nausea/vomiting

250

Abdominal pain

251

Malaise and fatigue

252

Device, implant, graft complications
Others

237
89, 92, 136, 137, 165–167,
171,175,182,187,189,193, 199, 253, 254, 257, 259

x, the ICD-9CM subcode; ICD-9CM, International Classification of Diseases, Ninth Edition, Clinical Modification; CCS, Clinical
Classification Software; COPD, chronic obstructive lung disease; AMI, acute myocardial infarction; CAD, coronary artery disease; UTI,
urinary tract infection; AKI, acute kidney injury.

